Trexquant Investment LP Vericel Corp Transaction History

Trexquant Investment LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $1.32 Million - $1.67 Million	31,564 Added 51.94%	92,331 $4.24 Million
Q1 2024 May 14, 2024	BUY	$32.52 - $52.33 $549,100 - $883,592	16,885 Added 38.48%	60,767 $3.16 Million
Q4 2023 Feb 09, 2024	BUY	$30.85 - $37.09 $23,538 - $28,299	763 Added 1.77%	43,882 $1.56 Million
Q3 2023 Nov 13, 2023	SELL	$31.69 - $39.25 $1.6 Million - $1.98 Million	-50,344 Reduced 53.87%	43,119 $1.45 Million
Q2 2023 Aug 11, 2023	BUY	$29.0 - $38.37 $1.12 Million - $1.48 Million	38,576 Added 70.28%	93,463 $3.51 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $1.31 Million - $1.72 Million	54,887 New	54,887 $1.61 Million
Q4 2020 Feb 11, 2021	SELL	$18.53 - $31.5 $705,548 - $1.2 Million	-38,076 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$14.68 - $19.12 $107,017 - $139,384	7,290 Added 23.68%	38,076 $706,000
Q2 2020 Aug 07, 2020	BUY	$8.5 - $15.82 $261,681 - $487,034	30,786 New	30,786 $425,000
Q1 2020 May 08, 2020	SELL	$7.25 - $19.22 $99,593 - $264,025	-13,737 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$13.77 - $19.2 $189,158 - $263,750	13,737 New	13,737 $239,000
Q1 2019 May 13, 2019	SELL	$16.23 - $20.29 $364,184 - $455,287	-22,439 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $241,668 - $413,775	22,439 New	22,439 $390,000
Q3 2018 Nov 09, 2018	SELL	$9.1 - $14.8 $501,828 - $816,160	-55,146 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$9.6 - $14.6 $179,136 - $272,436	18,660 Added 51.14%	55,146 $535,000
Q1 2018 May 03, 2018	BUY	$5.7 - $12.3 $207,970 - $448,777	36,486 New	36,486 $363,000

276

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.